MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

21 Mar 2022 Evaluate
Alembic Pharmaceuticals has informed that it has enclosed press release titled, ‘Alembic Pharmaceuticals receives USFDA Final Approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg, and 200 m’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..